Home / Research library / AHK-Cu
AHK-Cu: molecular data, studies & sources
AHK-Cu is catalogued here as an identity or preparation requiring extra specification. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
Molecular record not yet resolved
Copper coordination, protonation and counterions change the formula of AHK-Cu. The retrieved record contains hydrochloride and cannot establish the identity of an unspecified supplier complex.
MF: not assigned · MW: not assigned · Structure: not assigned
Registered clinical trials
Studies registered on ClinicalTrials.gov that list AHK-Cu as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received AHK-Cu, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
The effect of tripeptide-copper complex on human hair growth in vitro.
Pyo HK, Yoo HG, Won CH et al. · Archives of pharmacal research · 2007
PMID 17703734 · DOI: 10.1007/BF02978833
AHK-Cu supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
AHK-Cu for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino ClubUSD | 50mg Vial · 100mg Vial2 recorded offers | 50mg Vial · $34.99Stale observation · Checked Oct 14, 2026Supplier listing, AHK-Cu 50mg Vial, Amino Club, opens in a new tab |
| Cenexa LabsUSD | 200mg Powder1 recorded offers | 200mg Powder · $194.99Checked Nov 6, 2026Supplier listing, AHK-Cu 200mg Powder, Cenexa Labs, opens in a new tab |
| LA PeptidesUSD | 100mg Vial1 recorded offers | 100mg Vial · $49.99Checked Nov 3, 2026Supplier listing, AHK-Cu 100mg Vial, LA Peptides, opens in a new tab |
Reference sources & further reading
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Acetyl Hexapeptide-3 (Argireline)
C35H62N14O11S
887.0 g/mol · PubChem CID 71587772
6 selected publications · 1 human intervention study · 3 registered trials
Decapeptide-12
Molecular identity needs further verification
3 selected publications · 2 human intervention studies
GHK Basic (Tripeptide-1)
Molecular identity needs further verification
5 selected publications · 0 human intervention studies
Kisspeptin-10
C63H83N17O14
1302.4 g/mol · PubChem CID 25240297
5 selected publications · 3 human intervention studies · 5 registered trials
Protein / peptide · highest stage: Phase 3
Lipopeptide (Biopeptide EL)
Molecular identity needs further verification
Source verification pending
0 selected publications · 0 human intervention studies
Matrixyl
C39H75N7O10
802.1 g/mol · PubChem CID 9897237
4 selected publications · 0 human intervention studies